IPO

Jeb Hensarling [Photo: Grant Miller Photograhy/Venture Dallas]

The Last Word: TXSE’s Jeb Hensarling on a $300M War Chest, ARK Listings, and a ‘Transfer Portal’ Flowing to Texas

by | Apr 23, 2026
In a Bloomberg interview with Julie Fine, the former congressman laid out TXSE's timeline: trading this summer, listings in Q4, and first IPOs in Q1 2027.
MORE
Texas Stock Exchange Snags Key Leaders From Nasdaq and NYSE
by | Mar 24, 2026
The appointments of Greg Ferrari, formerly of Nasdaq, as COO and of Liz Hocker, formerly of NYSE Texas, as global head of listings and capital markets highlight TXSE's "robust momentum" as it prepares to come online later this year, the company said.
MORE
Irving’s Caris Life Sciences Files for IPO, Backed by AI-Driven Precision Oncology Platform
by | May 28, 2025
With $1.86 billion raised since 2018 and recent product launches, the North Texas life science company founded in 2008 is preparing for a public debut on the Nasdaq Global Select Market, following a $168 million growth capital round in April.
MORE
North Texas’ Solera Corp. Files Paperwork for IPO; Seeks $10-13 Billion Valuation, per Bloomberg
by | Jul 18, 2024

Solera Corp., the Westlake-based global provider of SaaS solutions for the vehicle lifecycle ecosystem, announced in late June that it has filed a registration statement with the U.S....

MORE

Dallas’ Apex Fintech Solutions Files for IPO In Its Second Go-Public Bid

by | Dec 13, 2023
Two years after attempting to go public via a SPAC merger that valued it at $4.7 billion post-money, Apex is looking to do it the old-fashioned way with a direct SEC filing. The "fintech for fintechs" has more than 220 clients with over $115 billion in assets under custody, with 21 million brokerage accounts and active investors in 144 countries.
MORE
Fort Worth’s TXO Energy Partners Announces Launch of Initial Public Offering
by | Jan 19, 2023
Newly renamed from Morningstar Partners LP, TXO Energy Partners has applied to list its common units on the New York Stock Exchange under the ticker symbol “TXO.” The initial public offering price is expected to be between $19 and $21 per common unit.
MORE
DSW Dispatches: Investors Offer Tips on Navigating the Changing Startup Economy
by | Aug 11, 2022
At Dallas Startup Week today, three leading early-stage investors offered tips on how founders should pivot in today's shifting economy. Perkins Coie's Valeska Pederson Hintz, LiveOak Venture Partners’ Mike Marcantonio, and S3 Ventures' Eric Engineer shared insights and advice. Despite the downturn, "If you've got a capital-efficient, growing business that has strong unit economics, at the end of the day that business is fundable, and that's what we're looking for," Marcantonio said.
MORE
Dallas Cybersecurity Company Acquired by Former U.S. Secretary of Treasury-Owned Firm in a $525M Deal
by | Mar 29, 2022
Dallas-based Zimperium, a mobile security platform, is set to be acquired by Washington, D.C.’s Liberty Strategic Capital, a firm led by former Goldman Sachs CIO and Trump Administration appointee Steve Mnuchin.
MORE

Nearly One Year After IPO, Signify Health Rolls Out Partner Program for Home-Based Healthcare

by | Jan 12, 2022
Signify Health is walking the walk to making healthcare more accessible outside healthcare facility walls.  This week, the company launched a new Partner Program with seven initial partners. The value-based ecosystem is focused on improving home healthcare through connecting hospitals, health systems, payers, and patients nationwide.
MORE
NuZee coffee
Tea-Bag Coffee Innovator Appoints Former Sony CEO and Quantum Leaps Co-CEO as Advisors
by | Dec 19, 2021
Advisor Nobuyuki Idei says NuZee's approach to its "eco-friendly coffee product innovation" is a great opportunity to tap into one of the world's largest coffee markets.
MORE
The sale of Trammell Crow Center was the top DFW CRE deal for 2022.
Global Dermatology Innovator Galderma Moving U.S. Headquarters to Downtown Dallas
by | Dec 10, 2021
One of the world's largest independent dermatology companies, Galderma's portfolio includes well-known brands such as Cetaphil, Proactiv, Differin, and Restylane. The Swiss company, whose ties to Texas date back to 1961, will call Trammell Crow Center in the Arts District home.
MORE

Irving’s AgileThought to Go Public Following Deal With Mexico-Based SPAC

by | May 10, 2021
The combined company will have an anticipated market value of $491 million. "For the past few years our focus has been exponential growth, mainly in the North American market," the team told us. "The move to public market facilitates this even more."
MORE
New York Fintech Katapult Makes Executive Hires Following an HQ Move to Plano
by | Apr 26, 2021
Katapult, a growing player in the "buy now pay later" market, is also getting ready to go public following a merger with SPAC FinServ Acquisition Corp.
MORE
Plano-Based Alkami Plans IPO Launch at $2B Valuation
by | Apr 5, 2021
Alkami, under the ticker symbol ALKT, is looking to raise $141 million by selling 6 million shares of its common stock at an expected price of $22-25 per share.
MORE
Success in the Genes: Launching in a Pandemic Didn’t Hurt This Fast-Growth Dallas Biotech Company
by | Feb 26, 2021
In under six months, Taysha Gene Therapies rocketed from the unveiling of its UTSW spinout to a $157 million initial public offering. We talk with Founder and CEO R.A. Session II about the biotech with big plans.
MORE